Pfizer Inc.'s (Jobs) Lipitor Patent Reissue Rejected

NEW YORK (Reuters) - A bid by Pfizer Inc. (PFE.N: Quote, Profile, Research) to win reissuance of a U.S. patent protecting its blockbuster Lipitor cholesterol medicine has been rejected on a preliminary basis, the company said on Friday.

Back to news